Global Antifungal Drugs Market Size, Share, Trends, Industry Growth by Drug Type (Azoles, Polyenes, Allylamines, Echinocandins, Others), by Indication (Aspergillosis, Dermatophytosis, Candidiasis, Others), by Form, by Region, and Forecast to 2027

Price: 3600/- USD | Published Date: December 12, 2021 |

The global antifungal drugs market size is accounted to grow at a significant CAGR of over 3% during the forecast period 2021 to 2027. The rising prevalence of fungal infection around the world is a primary factor to drive market growth. Furthermore, the increasing awareness among people and the growing number of OTC antifungal drugs are further anticipated to boost the market growth over the forecast period. Moreover, the increasing focus of the manufacturer to develop advanced formulation drugs and increasing use of nanotechnology in formulation for better clinical outcomes is expected to drive the market growth.

Market Segment Insights:

The global antifungal drugs market is bifurcated into drug type, indication, form, and geography. On the basis of drug type, the market is further segmented into azoles, polyenes, allylamines, echinocandins, and others. The azoles segment dominated the global market in 2020 and accounted to hold the largest revenue share of over one-third percent of the market by the end of the analysis period. The widespread use of the drug to treat yeast infection, candidemia, and ocular fungal infection is a major factor to drives the segment growth. Furthermore, the drug is also used to treat systemic fungal infection, which is further expected to fuel the segment growth.

Antifungal Drugs Market Size

To know more about the report, request sample papers

The antifungal drugs comprehensive study analyzes industry trends, market size, competitive analysis, and market forecast – 2021 to 2027. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.

The antifungal drugs market research report presents the analysis of each segment from 2018 to 2027 considering 2020 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2021 to 2027.

Historical & Forecast Period

  • 2018-19 – Historical Year
  • 2020 – Base Year
  • 2021-2027 – Forecast Period

Global Antifungal Drugs Market Segmentation:

By Drug Type:

  • Azoles
  • Polyenes
  • Allylamines
  • Echinocandins
  • Others

By Indication:

  • Aspergillosis
  • Dermatophytosis
  • Candidiasis
  • Others

By Form:

  • Powder
  • Ointments
  • Tablets
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Antifungal Drugs Market: Geographic Coverage

Geographically, North America dominated the global antifungal drugs market in 2020 and is estimated to hold the largest revenue share of over one-third percent of the market by the end of the analysis period. The increasing prevalence of fungal infection has resulted in an increase in demand for these drugs which is a major factor to drive the market growth in the region. Furthermore, the increasing awareness and the growing adoption of advanced treatment is further anticipated to boost the market growth in North America. On the flip side, the Asia Pacific is expected to register the highest growth rate over the forecast period.

Antifungal Drugs Market: Competitive Assessment

Some of the major market players operating in the global antifungal drugs market are Astellas Pharma, Inc., Merck & Co., Inc., Abbott Laboratories, Bayer AG, and Glenmark. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

List of Key Companies:

  • Astellas Pharma, Inc.
  • Merck & Co., Inc.
  • Abbott Laboratories
  • Bayer AG
  • Glenmark
  • GlaxoSmithKline PLC
  • Novartis AG
  • Pfizer Inc.
  • Sanofi-Aventis
  • Enzon Pharmaceuticals, Inc.

Key Questions Answered by Antifungal Drugs Market Report

  • Global antifungal drugs market forecasts from 2021-2027
  • Regional antifungal drugs market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
  • Country-level forecasts from 2021-2027 covering 15 major countries from the regions as mentioned above
  • Antifungal drugs submarket forecasts from 2021-2027 covering the market by drug type, by indication, by form, and geography
  • Various industry models such as SWOT analysis, Value Chain Analysis about antifungal drugs market
  • Analysis of the key factors driving and restraining the growth of the global, regional, and country-level antifungal drugs markets from 2021-2027
  • Competitive Landscape and market positioning of top 10 players operating in the antifungal drugs market
Table of Content:

1. Preface


1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions

 

2. Executive Summary


2.1. Global Antifungal Drugs Market Portraiture
2.2. Global Antifungal Drugs Market, by Drug Type, 2020 (USD Mn)
2.3. Global Antifungal Drugs Market, by Indication, 2020 (USD Mn)
2.4. Global Antifungal Drugs Market, by Form, 2020 (USD Mn)
2.5. Global Antifungal Drugs Market, by Geography, 2020 (USD Mn)

 

3. Global Antifungal Drugs Market Analysis


3.1. Antifungal Drugs Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. Porter’s Five Force Analysis
3.6.1. Bargaining Power of Suppliers
3.6.2. Bargaining Power of Buyers
3.6.3. Threat of New Entrants
3.6.4. Threat of Substitutes
3.6.5. Degree of Competition
3.7. COVID-19 Impact Analysis

 

4. Global Antifungal Drugs Market By Drug Type, 2018 – 2027 (USD Mn)


4.1. Overview
4.2. Azoles
4.3. Polyenes
4.4. Allylamines
4.5. Echinocandins
4.6. Others

 

5. Global Antifungal Drugs Market By Indication, 2018 – 2027 (USD Mn)


5.1. Overview
5.2. Aspergillosis
5.3. Dermatophytosis
5.4. Candidiasis
5.5. Others

 

6. Global Antifungal Drugs Market By Form, 2018 – 2027 (USD Mn)


6.1. Overview
6.2. Powder
6.3. Ointments
6.4. Tablets
6.5. Others

 

7. North America Antifungal Drugs Market Analysis and Forecast, 2018 – 2027 (USD Mn)


7.1.1. Overview
7.1.2. North America Antifungal Drugs Market by Drug Type (2018-2027 USD Mn)
7.1.3. North America Antifungal Drugs Market by Indication (2018-2027 USD Mn)
7.1.4. North America Antifungal Drugs Market by Form (2018-2027 USD Mn)
7.1.5. North America Antifungal Drugs Market by Country (2018-2027 USD Mn)
7.1.5.1. U.S.
7.1.5.1.1. U.S. Antifungal Drugs Market by Drug Type (2018-2027 USD Mn)
7.1.5.1.2. U.S. Antifungal Drugs Market by Indication (2018-2027 USD Mn)
7.1.5.1.3. U.S. Antifungal Drugs Market by Form (2018-2027 USD Mn)
7.1.5.2. Canada
7.1.5.2.1. Canada Antifungal Drugs Market by Drug Type (2018-2027 USD Mn)
7.1.5.2.2. Canada Antifungal Drugs Market by Indication (2018-2027 USD Mn)
7.1.5.2.3. Canada Antifungal Drugs Market by Form (2018-2027 USD Mn)

 

8. Europe Antifungal Drugs Market Analysis and Forecast, 2018 – 2027 (USD Mn)


8.1.1. Overview
8.1.2. Europe Antifungal Drugs Market by Drug Type (2018-2027 USD Mn)
8.1.3. Europe Antifungal Drugs Market by Indication (2018-2027 USD Mn)
8.1.4. Europe Antifungal Drugs Market by Form (2018-2027 USD Mn)
8.1.5. Europe Antifungal Drugs Market by Country (2018-2027 USD Mn)
8.1.5.1. Germany
8.1.5.1.1. Germany Antifungal Drugs Market by Drug Type (2018-2027 USD Mn)
8.1.5.1.2. Germany Antifungal Drugs Market by Indication (2018-2027 USD Mn)
8.1.5.1.3. Germany Antifungal Drugs Market by Form (2018-2027 USD Mn)
8.1.5.2. U.K.
8.1.5.2.1. U.K. Antifungal Drugs Market by Drug Type (2018-2027 USD Mn)
8.1.5.2.2. U.K. Antifungal Drugs Market by Indication (2018-2027 USD Mn)
8.1.5.2.3. U.K. Antifungal Drugs Market by Form (2018-2027 USD Mn)
8.1.5.3. France
8.1.5.3.1. France Antifungal Drugs Market by Drug Type (2018-2027 USD Mn)
8.1.5.3.2. France Antifungal Drugs Market by Indication (2018-2027 USD Mn)
8.1.5.3.3. France Antifungal Drugs Market by Form (2018-2027 USD Mn)
8.1.5.4. Italy
8.1.5.4.1. Italy Antifungal Drugs Market by Drug Type (2018-2027 USD Mn)
8.1.5.4.2. Italy Antifungal Drugs Market by Indication (2018-2027 USD Mn)
8.1.5.4.3. Italy Antifungal Drugs Market by Form (2018-2027 USD Mn)
8.1.5.5. Rest of Europe
8.1.5.5.1. Rest of Europe Antifungal Drugs Market by Drug Type (2018-2027 USD Mn)
8.1.5.5.2. Rest of Europe Antifungal Drugs Market by Indication (2018-2027 USD Mn)
8.1.5.5.3. Rest of Europe Antifungal Drugs Market by Form (2018-2027 USD Mn)

 

9. Asia Pacific Antifungal Drugs Market Analysis and Forecast, 2018 – 2027 (USD Mn)


9.1.1. Overview
9.1.2. Asia Pacific Antifungal Drugs Market by Drug Type (2018-2027 USD Mn)
9.1.3. Asia Pacific Antifungal Drugs Market by Indication (2018-2027 USD Mn)
9.1.4. Asia Pacific Antifungal Drugs Market by Form (2018-2027 USD Mn)
9.1.5. Asia Pacific Antifungal Drugs Market by Country (2018-2027 USD Mn)
9.1.5.1. China
9.1.5.1.1. China Antifungal Drugs Market by Drug Type (2018-2027 USD Mn)
9.1.5.1.2. China Antifungal Drugs Market by Indication (2018-2027 USD Mn)
9.1.5.1.3. China Antifungal Drugs Market by Form (2018-2027 USD Mn)
9.1.5.2. Japan
9.1.5.2.1. Japan Antifungal Drugs Market by Drug Type (2018-2027 USD Mn)
9.1.5.2.2. Japan Antifungal Drugs Market by Indication (2018-2027 USD Mn)
9.1.5.2.3. Japan Antifungal Drugs Market by Form (2018-2027 USD Mn)
9.1.5.3. Rest of Asia Pacific
9.1.5.3.1. Rest of Asia Pacific Antifungal Drugs Market by Drug Type (2018-2027 USD Mn)
9.1.5.3.2. Rest of Asia Pacific Antifungal Drugs Market by Indication (2018-2027 USD Mn)
9.1.5.3.3. Rest of Asia Pacific Antifungal Drugs Market by Form (2018-2027 USD Mn)

 

10. Latin America (LATAM) Antifungal Drugs Market Analysis and Forecast, 2018 – 2027 (USD Mn)


10.1.1. Overview
10.1.2. Latin America Antifungal Drugs Market by Drug Type (2018-2027 USD Mn)
10.1.3. Latin America Antifungal Drugs Market by Indication (2018-2027 USD Mn)
10.1.4. Latin America Antifungal Drugs Market by Form (2018-2027 USD Mn)
10.1.5. Latin America Antifungal Drugs Market by Country (2018-2027 USD Mn)
10.1.5.1. Brazil
10.1.5.1.1. Brazil Antifungal Drugs Market by Drug Type (2018-2027 USD Mn)
10.1.5.1.2. Brazil Antifungal Drugs Market by Indication (2018-2027 USD Mn)
10.1.5.1.3. Brazil Antifungal Drugs Market by Form (2018-2027 USD Mn)
10.1.5.2. Mexico
10.1.5.2.1. Mexico Antifungal Drugs Market by Drug Type (2018-2027 USD Mn)
10.1.5.2.2. Mexico Antifungal Drugs Market by Indication (2018-2027 USD Mn)
10.1.5.2.3. Mexico Antifungal Drugs Market by Form (2018-2027 USD Mn)
10.1.5.3. Rest of Latin America
10.1.5.3.1. Rest of Latin America Antifungal Drugs Market by Drug Type (2018-2027 USD Mn)
10.1.5.3.2. Rest of Latin America Antifungal Drugs Market by Indication (2018-2027 USD Mn)
10.1.5.3.3. Rest of Latin America Antifungal Drugs Market by Form (2018-2027 USD Mn)

 

11. Middle East and Africa Antifungal Drugs Market Analysis and Forecast, 2018 – 2027 (USD Mn)


11.1.1. Overview
11.1.2. MEA Antifungal Drugs Market by Drug Type (2018-2027 USD Mn)
11.1.3. MEA Antifungal Drugs Market by Indication (2018-2027 USD Mn)
11.1.4. MEA Antifungal Drugs Market by Form (2018-2027 USD Mn)
11.1.5. Middle East and Africa Antifungal Drugs Market, by Country (2018-2027 USD Mn)
11.1.5.1. GCC
11.1.5.1.1. GCC Antifungal Drugs Market by Drug Type (2018-2027 USD Mn)
11.1.5.1.2. GCC Antifungal Drugs Market by Indication (2018-2027 USD Mn)
11.1.5.1.3. GCC Antifungal Drugs Market by Form (2018-2027 USD Mn)
11.1.5.2. South Africa
11.1.5.2.1. South Africa Antifungal Drugs Market by Drug Type (2018-2027 USD Mn)
11.1.5.2.2. South Africa Antifungal Drugs Market by Indication (2018-2027 USD Mn)
11.1.5.2.3. South Africa Antifungal Drugs Market by Form (2018-2027 USD Mn)
11.1.5.3. Rest of MEA
11.1.5.3.1. Rest of MEA Antifungal Drugs Market by Drug Type (2018-2027 USD Mn)
11.1.5.3.2. Rest of MEA Antifungal Drugs Market by Indication (2018-2027 USD Mn)
11.1.5.3.3. Rest of MEA Antifungal Drugs Market by Form (2018-2027 USD Mn)

 

12. Company Profiles


12.1. Astellas Pharma, Inc.
12.1.1. Business Description
12.1.2. Financial Health and Budget Allocation
12.1.3. Product Positions/Portfolio
12.1.4. Recent Development
12.1.5. SWOT Analysis
12.2. Merck & Co., Inc.
12.2.1. Business Description
12.2.2. Financial Health and Budget Allocation
12.2.3. Product Positions/Portfolio
12.2.4. Recent Development
12.2.5. SWOT Analysis
12.3. Abbott Laboratories
12.3.1. Business Description
12.3.2. Financial Health and Budget Allocation
12.3.3. Product Positions/Portfolio
12.3.4. Recent Development
12.3.5. SWOT Analysis
12.4. Bayer AG
12.4.1. Business Description
12.4.2. Financial Health and Budget Allocation
12.4.3. Product Positions/Portfolio
12.4.4. Recent Development
12.4.5. SWOT Analysis
12.5. Glenmark
12.5.1. Business Description
12.5.2. Financial Health and Budget Allocation
12.5.3. Product Positions/Portfolio
12.5.4. Recent Development
12.5.5. SWOT Analysis
12.6. GlaxoSmithKline PLC
12.6.1. Business Description
12.6.2. Financial Health and Budget Allocation
12.6.3. Product Positions/Portfolio
12.6.4. Recent Development
12.6.5. SWOT Analysis
12.7. Novartis AG
12.7.1. Business Description
12.7.2. Financial Health and Budget Allocation
12.7.3. Product Positions/Portfolio
12.7.4. Recent Development
12.7.5. SWOT Analysis
12.8. Pfizer Inc.
12.8.1. Business Description
12.8.2. Financial Health and Budget Allocation
12.8.3. Product Positions/Portfolio
12.8.4. Recent Development
12.8.5. SWOT Analysis
12.9. Sanofi-Aventis
12.9.1. Business Description
12.9.2. Financial Health and Budget Allocation
12.9.3. Product Positions/Portfolio
12.9.4. Recent Development
12.9.5. SWOT Analysis
12.10. Enzon Pharmaceuticals, Inc.
12.10.1. Business Description
12.10.2. Financial Health and Budget Allocation
12.10.3. Product Positions/Portfolio
12.10.4. Recent Development
12.10.5. SWOT Analysis
Fill the given form to inquiry before buying for Global Antifungal Drugs Market Size, Share, Trends, Industry Growth by Drug Type (Azoles, Polyenes, Allylamines, Echinocandins, Others), by Indication (Aspergillosis, Dermatophytosis, Candidiasis, Others), by Form, by Region, and Forecast to 2027 Market Report

(Additional country analysis and conmapny analysis will be added according to the request, we provide free report customization)
(Report covers the impact of COVID-19 on the market)

Request Report Sample
Inquiry Before Buying


Select License Type
$ 3600/- Single User License
$ 4800/- Multi User License
$ 6800/- Corporate License

Paypal Certified Payment
Why To Choose Us:
  • Markets in over 100+ countries analyzed granularly
  • 35% of our total client are returning clients
  • 1000+ customers globally
  • 100+ paid data sources mined to bring cutting-edge insights
  • 24x5 availability - we are always there when you need us
  • "Free of Cost Report Customization" is available
  • Request a regional report at Best Price
  • Our expert team will assist you with all research need and customization
  • Our expert research analysts will resolve your every query before and after purchasing the report

Impacts of COVID-19
COVID-19 Impact on the Global Antifungal Drugs Market Size, Share, Trends, Industry Growth by Drug Type (Azoles, Polyenes, Allylamines, Echinocandins, Others), by Indication (Aspergillosis, Dermatophytosis, Candidiasis, Others), by Form, by Region, and Forecast to 2027 Market


Our Clients